The New York Daily News reports:
After being discharged from a premier hospital on Thursday, Rudy Giuliani revealed his treatment for COVID-19 included an experimental drug that is in such short supply that some states have set up lotteries to determine which patients should be lucky enough to receive a dose. Giuliani, 76, confirmed in a text message to the Daily News that he received Regeneron’s monoclonal antibody cocktail during his five-day stay at Georgetown University Hospital in Washington, D.C.
According to this HHS document, Washington DC was given all of 108 doses of Regeneron’s monoclonal antibody cocktail. Somehow Rudy Giuliani qualified for one of them. https://t.co/2dblc0bvcf
— Michelle Goldberg (@michelleinbklyn) December 10, 2020
What do Trump, Giuliani, Christie & Carson have in common?
1. They all got covid, denounced the need for masks, mitigations
2. They all received monoclonal antibodies and bragged it saved their lives
3. They are in a rarified group of very few people who can get this treatment
— Eric Topol (@EricTopol) December 9, 2020
📍Giuliani has quite the gall—gets fancy synthetic monoclonal antibody therapy that doctors/nurses can’t even easily get for themselves. Yet he’s oblivious of his VIP privilege.
— Eric Feigl-Ding (@DrEricDing) December 10, 2020